Stroke Finder Helmet Part 1 - Acute Care of Stroke Patients
moreProfessor Mark Parsons
![]() ![]()
2017
Project Grant
|
![]() ![]()
2016
Project Grant
|
![]() ![]()
2015
Project Grant
|
![]() ![]()
2014
Project Grant
|
![]() ![]()
2014
Project Grant
|
![]() ![]()
2014
Project Grant
|
![]() ![]()
2013
Fellowship
|
![]() ![]()
2013
Project Grant
|
![]() ![]()
2013
Project Grant
|
![]() ![]()
2012
Project Grant
|
![]() ![]()
2011
Scholarship
|
![]() ![]()
2011
Project Grant
|
![]() ![]()
2011
Project Grant
|
![]() ![]()
2011
Project Grant
|
![]() ![]()
2010
Scholarship
|
![]() ![]()
2010
Project Grant
|
![]() ![]()
2009
Project Grant
|
![]() ![]()
2007
Project Grant
|
![]() ![]()
2007
Project Grant
|
![]() ![]()
2007
HMRI Award for Early Career Research
|
![]() ![]()
2007
Fellowship
|
![]() ![]()
2005
Project Grant
|
![]() ![]()
2005
Project Grant
|
Professor Mark Parsons is regarded as one of Australia’s leading clinical stroke and brain imaging researchers. In 2003, he began leading the stroke imaging research group within the HMRI Stroke Research Group and established a laboratory at John Hunter Hospital.
Using magnetic resonance (MRI) and CT imaging techniques, Professor Parsons’ brain imaging research is already being adopted in clinical practice to improve the selection of patients for acute stroke therapies involving clot-dissolving treatments which can reduce a stroke patient’s level of disability and lead to a quicker recovery when administered immediately after a stroke.
Professor Parsons’ PhD thesis detailed the use of modern MRI techniques in acute stroke, from which he published several scientific papers in high-impact international journals. He had particular interests in the effects of certain drugs in breaking up the blood clots that cause stroke and in salvaging brain tissue from sections that are not damaged permanently by stroke, known as the ischaemic penumbra.
Professor Parsons has also demonstrated the ability to translate fundamental research in the laboratory and clinic into solutions with a direct practical application in clinical practice. He has experience in the re-design and evaluation of health systems, often a critical step in the implementation of complex therapies such as stroke clot-busting drugs.
Professor Parsons led the development of an ambulance protocol in the Hunter Region for the rapid identification, pre-hospital notification, and rapid transport of potential patients suitable for clot-busting drugs to a specialist stroke centre.
This means that thanks to Professor Parsons’ groundbreaking research, a specialist neurologist will likely be waiting at the hospital when an ambulance arrives with a stroke patient on board, armed with the knowledge of what type of stroke they have suffered and how to treat it immediately and effectively.
In 2012, Professor Parsons and his colleagues found that a clot-busting medication called called Tenecteplase was superior to the standard therapy for stroke, Alteplase. He has led clinical trials in this area with very promising results and is now coordinating an internationally trial of tenecteplase for the treatment of stroke at over 50 centres worldwide.
Professor Parsons’ research interests also include the adverse effects of diabetes on stroke outcomes and neurological rehabilitation and recovery. His findings linking high blood sugar and adverse stroke outcomes have had major implications for research in this field and potentially, clinical guidelines in the future.
Professor Mark Parsons is the current President of the Stroke Society of Australasia, the Director of the Acute Stroke Unit at the John Hunter Hospital and an Honorary Neurologist at the Royal Melbourne Hospital. He has won many awards in his field including the HMRI Award for Excellence in Brain and Mental Health Research in 2004, the HMRI Award for Early Career Researcher in 2007 and the HMRI Director’s Award for Mid-Career Researcher in 2014.
Christopher Levi, Prof Michael Nilsson, Prof Mark Parsons, A/Prof Rohan Walker
Stroke Finder Helmet Part 1 - Acute Care of Stroke Patients
moreStroke causes a major global disease burden due to the long lasting disability of survivors.
moreThe proposed project is highly significant because it will, for the first time, to accurately map the changes that occur in the brain following stoke and identify patters for good clinical outcomes.
moreDr Renate Thienel, Frini Karayanidis, Juanita Todd, Peter Stanwell, Mark Parsons, Chris Levi
Mapping networks in the brain
moreProfessor Christopher Levi, J. Sturmm, Mark Parsons, Neil Spratt, A. Loiselle, B. O'Brien, V. Zenteno, L.Holliday, Rodney Scott, J. Maguire
Stroke is the leading cause of long-term disability in Australia and the second leading cause of death.
moreThis funding was provided to fund the vanguard phase of two clinical trials in stroke:
moreAssociate Professor Frini Karayanidis, Pat Michie, Tod Jolly, Pat Cooper, Clevi, Mark Parsons, Peter Scholfield
Dr Mark Parsons, Dr PT Stanwell
Dr Damien McLeod, Dr Neil Spratt, Associate Professor Mark Parsons, Professor Chris Levi
Dr Frini Karayanidis, Mark Parsons, Chris Levi, Grant Bateman, Patricia Michie, Peter Schofield & Todd Jolly
Dr Frini Karayanidis, Mark Parsons, Chris Levi, Grant Bateman, Patricia Michie, Peter Schofield & Todd Jolly
Dr Frini Karayanidis, Mark Parsons, Patricia Michie, Christopher Levi, Sharna Jamadar, Matthew Hughes, Peter Schofield, Dr Grant Bateman
Dr Neil Spratt, Dr Mark Parsons, Dr Damian McLeod; Conjoint Associate Professor Christopher Levi
Dr Timothy Budd, Dr Mark Parsons, Dr Chris Levi
Dr Mark Parsons, Dr Bill Budd, Dr Chris Levi
Dr Christopher Levi, Professor Mike Calford, Dr Mark Parsons